| Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia S Manteniotis, R Lehmann, C Flegel, F Vogel, A Hofreuter, BSP Schreiner, ... PloS one 8 (11), e79523, 2013 | 138 | 2013 |
| Characterization of the olfactory receptors expressed in human spermatozoa C Flegel, F Vogel, A Hofreuter, BSP Schreiner, S Osthold, S Veitinger, ... Frontiers in molecular biosciences 2, 73, 2016 | 115 | 2016 |
| Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma R Váraljai, K Wistuba-Hamprecht, T Seremet, JMS Diaz, J Nsengimana, ... JCO precision oncology 3, 1-10, 2019 | 51 | 2019 |
| Ferroptosis in Health and Disease C Berndt, H Alborzinia, VS Amen, S Ayton, U Barayeu, A Bartelt, H Bayir, ... Redox Biology, 103211, 2024 | 46 | 2024 |
| Lipids as mediators of cancer progression and metastasis FCE Vogel, AB Chaves-Filho, A Schulze Nature Cancer 5 (1), 16-29, 2024 | 37 | 2024 |
| Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 C Flegel, F Vogel, A Hofreuter, S Wojcik, C Schoeder, K Kieć-Kononowicz, ... Scientific reports 6 (1), 32255, 2016 | 37 | 2016 |
| Targeting the H3K4 demethylase KDM5B reprograms the metabolome and phenotype of melanoma cells FCE Vogel, N Bordag, E Zügner, M Trajkovic-Arsic, H Chauvistré, ... Journal of Investigative Dermatology 139 (12), 2506-2516. e10, 2019 | 34 | 2019 |
| LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma H Alborzinia, Z Chen, U Yildiz, FP Freitas, FCE Vogel, JP Varga, J Batani, ... EMBO Molecular Medicine 15 (8), e18014, 2023 | 29 | 2023 |
| Persister state-directed transitioning and vulnerability in melanoma H Chauvistré, B Shannan, SM Daignault-Mill, RJ Ju, D Picard, ... Nature communications 13 (1), 3055, 2022 | 29 | 2022 |
| Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma B Shannan, J Matschke, H Chauvistré, F Vogel, D Klein, F Meier, ... European Journal of Cancer 109, 137-153, 2019 | 20 | 2019 |
| USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer CR Maier, O Hartmann, C Prieto-Garcia, KM Al-Shami, L Schlicker, ... Cell Death & Differentiation 30 (7), 1710-1725, 2023 | 9 | 2023 |
| Fatty acid synthesis enables brain metastasis FCE Vogel, A Schulze Nature Cancer 2 (4), 374-376, 2021 | 8 | 2021 |
| Selenocysteine metabolism is a targetable vulnerability in MYCN-amplified cancers H Alborzinia, Z Chen, U Yildiz, FP Freitas, FCE Vogel, J Varga, J Batani, ... bioRxiv, 2022.05. 17.492172, 2022 | 7 | 2022 |
| Zelkovamycin is an OXPHOS inhibitory member of the argyrin natural product family D Krahn, G Heilmann, FCE Vogel, C Papadopoulos, S Zweerink, ... Chemistry–A European Journal 26 (39), 8524-8531, 2020 | 6 | 2020 |
| p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells O Hassin, M Sernik, A Seligman, FCE Vogel, MD Wellenstein, J Smollich, ... Proceedings of the National Academy of Sciences 120 (52), e2311460120, 2023 | 3 | 2023 |
| S120: acute myeloid leukemia represents a ferroptosis-sensitive cancer entity raising the possibility for novel targeting strategies A Narr, H Alborzinia, E Donato, F Vogel, T Boch, AM Leppä, ... Hemasphere 6, 21-22, 2022 | 2 | 2022 |
| The Janus-faced role of KDM5B heterogeneity in melanoma: Differentiation as a situational driver of both growth arrest and drug-resistance H Chauvistré, S Daignault, B Shannan, R Ju, D Picard, F Vogel, ... bioRxiv, 2020 | 2 | 2020 |
| PO-332 Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E-inhibition in melanoma B Shannan, J Matschke, H Chauvistre, F Vogel, D Klein, F Meier, ... ESMO Open 3, A358, 2018 | 1 | 2018 |
| Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation MT Snaebjornsson, P Poeller, D Komkova, F Röhrig, L Schlicker, ... Nature Metabolism, 1-19, 2025 | | 2025 |
| Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in Cancer AM Winkelkotte, K Al-Shami, AB Chaves-Filho, FCE Vogel, A Schulze Cold Spring Harbor Perspectives in Medicine, a041548, 2024 | | 2024 |
